Renal dysfunction is a significant risk factor for acyclovir-induced neurotoxicity and altered mentation and myoclonic movements are the most common clinical symptoms observed. In majority of reported cases, neurological sequelae associated with acyclovir-induced neurotoxicity often mimic viral infections of the central nervous system and makes diagnosis of the former challenging. Although plasma concentrations of the drug may not always correlate with neurotoxic symptoms, obtaining serum levels of acyclovir may be helpful in confirming drug-induced neurotoxicity. Hemodialysis has been shown to significantly improve altered mentation in patients with suspected or confirmed acyclovir-induced neurotoxicity. Here, we report a definite case of acyclovir-induced neurotoxicity in a patient with end-stage renal disease. Clinical improvements in neurologic symptoms were observed following discontinuation of the drug and hemodialysis.
AdairJCGoldMBondRE. Acyclovir neurotoxicity: clinical experience and review of the literature. South Med J. 1994;87(12):1227–1231.
2.
RashiqSBriewaLMooneyMGiancarloTKhatibRWilsonFM. Distinguishing acyclovir neurotoxicity from encephalomyelitis. J Intern Med. 1993;234(5):507–511.
3.
HaefeliWESchoenenbergerRAZWeissPRitzRF. Acyclovir induced neurotoxicity: concentration side effect relationship in acyclovir overdose. J Am Med. 1993;94(2):212–215.
4.
SwanSKBennettWM. Oral acyclovir and neurotoxicity [letter]. Ann Intern Med. 1989;111(2):188.
5.
BealesPAlmondMKKwanJTC. Acyclovir neurotoxicity following oral therapy: prevention and treatment in patients on haemodialysis [letter]. Nephron. 1994;66(3):362–363.
6.
MacDiarmaid-GordonARO’ConnorM, et al.Neurotoxicity associated with oral acyclovir in patients undergoing dialysis. Nephron. 1992;62(3):280–283.
7.
TomsonCRGoodshipTHJRodgerRSC. Psychiatric side-effects of acyclovir in patients with chronic renal failure [letter]. Lancet. 1985;2(8451):385–386.
8.
BataillePDevosPNoelJL, et al.Psychiatric side-effects with acyclovir [letter]. Lancet. 1985;2(8457):724.
9.
RevankarSGApplegateALMarkovitzDM. Delirium associated with acyclovir treatment in a patient with renal failure. Clin Infect Dis. 1995;21(2):435–436.
10.
StrongDKHebertD. Acute acyclovir neurotoxicity in a hemodialyzed child. Pediatr Nephrol. 1997;11(6):741–743.
11.
DavenportAGoelSMacKenzieJC. Neurotoxicity of acyclovir in patients with end stage renal failure treated with continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1992;20(6):647–649.
12.
KitchingRFaggDHayNM, et al.Neurotoxicity associated with acyclovir in end stage renal failure. N Z Med J. 1997;110(1043):167–169.
13.
GillMJBurgessE. Neurotoxicity of acyclovir in end stage renal disease [letter]. J Antimicrob Chemother. 1990;25(2):300–301.
14.
JohnsonGLLimonLTrikhaG, et al.Acute renal failure and neurotoxicity following oral acyclovir. Ann Pharmacother. 1994;28(4):460–463.
15.
FletcherCVChinnockBJChaceB, et al.Pharmacokinetics and safety of high dose oral acyclovir for suppression of cytomegalovirus disease after renal transplantation. Clin Pharmacol Ther. 1988;44(2):158–163.
16.
KrigelRL. Reversible neurotoxicity due to oral acyclovir in a patient with chronic lymphocytic leukemia [letter]. J Infect Dis. 1986;154:189.
17.
WadeJCMeyersJD. Neurologic symptoms associated with parenteral acyclovir treatment after marrow transplantation. Ann Intern Med. 1983;98(6):921–925.
18.
BlohmMEGNurnbergerWAulichA, et al.Reversible brain MRI changes in acyclovir neurotoxicity. Bone Marrow Transplant. 1997;19(10):1049–1051.
19.
AuwerxJKnockaertDHofkensP. Acyclovir and neurologic manifestations [letter]. Ann Intern Med. 1983;99(6):882–883.
20.
JonesPGBeier-HanrattySA. Acyclovir: neurologic and renal toxicity [letter]. Ann Intern Med. 1986;104(6):892.
21.
FeldmanSRodmanJGregoryB. Excessive serum concentrations of acyclovir and neurotoxicity. J Infect Dis. 1988;157(2):385–388.
22.
SpiegalDMLauK. Acute renal failure and coma secondary to acyclovir therapy [letter]. JAMA. 1986;255(14):1882–1883.
23.
EckPSilverSMClarkEC. Acute renal failure and coma after a high dose of oral acyclovir [letter]. New Engl J Med. 1991;325(16):1178–1179.
24.
CohenSMZMinkoveJAZebleyJW3 rd, et al.Severe but reversible neurotoxicity from acyclovir [letter]. Ann Intern Med. 1984;100(6):920.
25.
VartianCVShlaesDM. Intravenous acyclovir and neurologic effects [letter]. Ann Intern Med. 1983;99(4):568.
26.
KriebleBFRudyDWGlickMR, et al.Case report: acyclovir neurotoxicity and nephrotoxicity—the role for hemodialysis. Am J Med Sci. 1993;305(1):36–39.
27.
AlmondMKFanSDhillonS, et al.Avoiding acyclovir neurotoxicity in patients with chronic renal failure undergoing hemodialysis. Nephron. 1995;69(4):428–432.
28.
RajanGRCCobbJPReissCK. Acyclovir induced coma in the intensive care unit. Anaesth Intensive Care. 2000;28(3):305–307.
29.
Gomez CampderaFJVerdeEVozmedianoMC, et al.More about acyclovir neurotoxicity in patients on hemodialysis [letter]. Nephron. 1998;78(2):228–229.
30.
MartinezGJHsiaR. Altered mental status from acyclovir. J Emerg Med. 2011;41(1):55–58.
31.
BatesD. Valacyclovir neurotoxicity: two case reports and a review of the literature. Can J Hosp Pharm. 2002;55:123–127.
32.
ChowdhuryMADerarNHasanS, et al.Acyclovir-induced neurotoxicity: a case report and review of literature. Am J Ther. 2016;23(3):e941–e943.
33.
BlumRMLiaoSHde MirandaP. Overview of acyclovir pharmacokinetic disposition in adults and children. Am J Med. 1982;73(1A):186–192.
34.
HelldénAOdar-CederlöfIDienerP, et al.High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational study. Nephrol Dial Transplant. 2003;18(6):1135–1141.
35.
SmithJPWellerSJohnsonB, et al.Pharmacokinetics of acyclovir and its metabolites in cerebrospinal fluid and systemic circulation after administration of high-dose valacyclovir in subjects with normal and impaired renal function. Antimicrob Agents Chemother. 2010;54(3):1146–1151.
36.
NaranjoCABustoUSellersEM, et al.A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245.
37.
LeikingJBShickerLOrlowskiJ, et al.Hemodialysis removal of acyclovir. Vet Hum Toxicol. 1995;37(3):233–234.
